Recently, there have been a number of technological advances which have revolutionized cell culture systems. These include the development of patient derived cells, such as iPSC’s, which more closely mimic the underlying pathological process of Parkinson’s and the development of 3D culture systems. Such platforms have the potential to accelerate drug discovery in Parkinson’s.
With this fellowship scheme, we are keen to support the development of neuroprotective treatments for Parkinson’s through the development and use of novel cell culture platforms
Funder: Parkinson’s UK and The Rosetrees Trust
Deadline: January 19, 2022
